Wiley Bros. Aintree Capital, LLC Zoetis Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 71,516 shares of ZTS stock, worth $11.5 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
71,516
Previous 62,097
15.17%
Holding current value
$11.5 Million
Previous $12.1 Million
3.96%
% of portfolio
0.14%
Previous 0.24%
Shares
4 transactions
Others Institutions Holding ZTS
# of Institutions
2,053Shares Held
419MCall Options Held
1.22MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA41.4MShares$6.64 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.91 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.18 Billion0.13% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.57 Billion2.4% of portfolio
-
Morgan Stanley New York, NY11.8MShares$1.9 Billion0.14% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $75.1B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...